Lower corporate taxes outside the U.S. is one driver of Minneapolis-based Medtronic’s purchase of Dublin-based Covidien. But it’s not the only tax consideration involved in medical device M&A. When Mergers & Acquisitions spoke with former Sen. Scott Brown at ACG Boston’s Growth Conference 2013, he warned that U.S. tax on medical devices in the Affordable […]
To read the entire story, you must be logged in.
Please log in now or register with us.
